[{"data":1,"prerenderedAt":434},["ShallowReactive",2],{"tool-healthcare-medlinker":3,"footer-total":406,"related-healthcare-medlinker":407},{"id":4,"title":5,"author":6,"bestFor":7,"body":8,"category":366,"cons":367,"cover":373,"date":374,"description":375,"draft":376,"extension":377,"meta":378,"navigation":379,"notFor":380,"path":381,"pricing":382,"pros":386,"region":392,"score":393,"scoreBreakdown":394,"seo":397,"stem":398,"tags":399,"toolName":216,"updated":374,"url":403,"vendor":404,"__hash__":405},"tools\u002Ftools\u002Fhealthcare\u002Fmedlinker.md","未来医生 评测","元析评测","研究临床决策辅助、想评估 AI 参与诊疗流程可行性的医院与机构",{"type":9,"value":10,"toc":338},"minimark",[11,15,23,26,29,48,51,54,59,62,65,69,72,75,79,82,85,88,91,94,97,101,104,108,111,115,118,122,125,129,132,135,199,202,205,295,301,305,309,312,316,319,323,326,329,332],[12,13,14],"h2",{"id":14},"结论先行",[16,17,18,22],"p",{},[19,20,21],"strong",{},"谨慎推荐,总分 7.4,官网一个价码都没挂,只能走销售。"," 未来医生(medlinker)已经不是传统意义上的在线问诊平台。首页讲的是 MedGPT 临床策略引擎:把一次判断拆成状态与目标、候选与证据、批判与修复、决策性验证、策略审阅包五步,再配 EvidenceOS 收支持与反方证据,由医生在 Medex 里修订。",[16,24,25],{},"它值得看的是架构思路,不是现成服务。首页多处标注\"架构机制演绎,非真实病例\",患者端的咨询意见也要真实接诊医生确认。个人想马上问诊,这里给不了;机构想评估 AI 进诊疗流程怎么做,这是国内少见的把流程拆开讲的样本。",[12,27,28],{"id":28},"这篇评测基于什么数据",[30,31,32,36,39,42,45],"ul",{},[33,34,35],"li",{},"官网首页(2026-11 核对):主张为\"医疗 AGI,从一个人出发\",导航分首页、患者服务、机构合作三块,机构合作下设 MedGPT、新闻中心、关于我们,另有英文站与 App 下载入口",[33,37,38],{},"MedGPT 流程:首页逐条列出状态与目标、候选与证据、批判与修复、决策性验证、策略审阅包五个步骤",[33,40,41],{},"Medex 演示:页面标注\"决策审阅 v.01\",展示医生补充\"患者更希望减少住院\"后,患者目标进入待确认、路径排序随之重算",[33,43,44],{},"患者端说明:设路径经理角色,全病程诊疗档案保存患者上下文与决策历史,页面写明\"产品状态演绎,非真实病例或履约记录\"",[33,46,47],{},"主体信息:站点署名\"未来医生—北京智医方程科技有限公司\",关于我们页链接到医联的发展历程;首页未见慢病续方、多点执业的入口,重心放在 MedGPT 与 Medex",[16,49,50],{},"我们只看了首页、MedGPT 与患者服务页,没登录 Medex,也没联系销售。文中的能力判断依据官网自述与页面结构,不含真实病例验证。未做统一环境实测,以下基于官网文档与公开资料。",[12,52,53],{"id":53},"核心功能",[55,56,58],"h3",{"id":57},"medgpt把一次判断拆成五步","MedGPT:把一次判断拆成五步",[16,60,61],{},"多数医疗 AI 产品只讲\"能回答什么\",MedGPT 讲的是判断怎么形成。第一步明确患者此刻的病情、既往治疗、现实约束与生活期待;第二步列候选方案并挂上证据;第三步自我批判,把反方证据和适用边界摆出来;第四步做决策性验证,确认下一步最值得查什么;第五步输出策略审阅包给医生。",[16,63,64],{},"这套拆法好在可追问:哪一步证据薄弱,医生能直接指出;哪一步目标写偏了,能回退重算。代价是流程重,轻症用不上,适合合并症多、治疗目标冲突的场景。",[55,66,68],{"id":67},"medex医生的修订进入推理","Medex:医生的修订进入推理",[16,70,71],{},"Medex 是医生侧的工作台。医生可以纠正事实、质疑证据、调整目标、审阅策略,一次修订不只是改个字段,系统会重算受影响的判断,并把改动原因留在记录里。首页演示的版本号是 v.01,说明这套东西还在打磨。",[16,73,74],{},"对医院来说,这个设计的看点是责任边界清楚:意见由医生署名,系统只给策略与替代路径。风险也在这里:v.01 意味着接口、权限、留痕规范都可能变,接入前要谈好升级与回滚。",[55,76,78],{"id":77},"患者端路径经理与全病程档案","患者端:路径经理与全病程档案",[16,80,81],{},"患者端不主打\"问医生\",主打\"有人负责\"。首页把角色描述为路径经理,负责把依据、分歧和下一步讲清楚;全病程档案保存上下文与决策历史,新材料进来时只重开受影响的判断,而不是推翻重来。",[16,83,84],{},"这套说法落到现实,关键在履约。页面写明咨询意见需要真实接诊与临床确认,说明线上环节到意见为止。买之前要问清楚:路径经理是谁、由哪家机构承担、出了分歧谁解释。",[55,86,87],{"id":87},"机构合作与英文站",[16,89,90],{},"首页给机构留了三条线:MedGPT 的产品说明、Medex 的体验入口、新闻中心与关于我们。机构合作页没有列接入方式、部署形态和计费口径,只有理念与流程。英文站是同一套内容的英文版,用词比中文更保守。",[16,92,93],{},"对医院信息科来说,最该问的三个问题是:能不能对接现有 HIS、病历数据留在哪、医生署名与责任怎么落。官网目前都没有答案,得进到商务沟通才清楚。",[12,95,96],{"id":96},"评分明细",[55,98,100],{"id":99},"功能完整度7810","功能完整度:7.8\u002F10",[16,102,103],{},"临床策略、证据管理、医生工作台、患者端档案四条线都画出来了,流程拆得比同类细。扣分在缺公开的落地清单:接入方式、数据接口、权限模型、审计留痕都没写。",[55,105,107],{"id":106},"易用性7410","易用性:7.4\u002F10",[16,109,110],{},"首页叙事清楚,一条主线从医生读到患者,流程条能看懂。扣分在自造术语多,EvidenceOS、策略审阅包、路径经理都要读两遍才明白。",[55,112,114],{"id":113},"数据质量7410","数据质量:7.4\u002F10",[16,116,117],{},"EvidenceOS 同时收支持证据与反方证据,思路比只喂指南稳。扣分在没有公开的验证数据:多少病例、由哪些医生盲评、与常规路径差多少,一条都没有。",[55,119,121],{"id":120},"性价比7110","性价比:7.1\u002F10",[16,123,124],{},"官网没有任何报价信息,套餐、开通条件、服务区域全部空白,无法判断贵不贵。这一项只能按透明度打分,等拿到报价单才能重估。",[55,126,128],{"id":127},"客户支持7410","客户支持:7.4\u002F10",[16,130,131],{},"有机构合作入口与体验申请,响应路径清楚,英文站也留着联系方式。扣分在没有公开的帮助中心、文档库或 FAQ,个人用户遇到问题找不到自助答案。",[12,133,134],{"id":134},"定价说明",[136,137,138,154],"table",{},[139,140,141],"thead",{},[142,143,144,148,151],"tr",{},[145,146,147],"th",{},"项目",[145,149,150],{},"价格",[145,152,153],{},"说明",[155,156,157,169,179,189],"tbody",{},[142,158,159,163,166],{},[160,161,162],"td",{},"患者端服务",[160,164,165],{},"官网未公开",[160,167,168],{},"未列问诊单价、会员价或服务包",[142,170,171,174,176],{},[160,172,173],{},"MedGPT 机构接入",[160,175,165],{},[160,177,178],{},"未列部署形态、接口费用与年费",[142,180,181,184,186],{},[160,182,183],{},"Medex 医生工作台",[160,185,165],{},[160,187,188],{},"标注 v.01,未列席位与授权方式",[142,190,191,194,196],{},[160,192,193],{},"英文站服务",[160,195,165],{},[160,197,198],{},"内容与中文站一致,无价目",[16,200,201],{},"官网未公开报价,需联系销售。这类面向机构的临床决策产品,报价通常按接入范围、并发医生数、数据治理工作量三块谈,不同医院差额能到数倍。采购前把需求写成清单:接几个科室、多少医生同时用、要不要对接 HIS 与 LIS、数据能不能出院内网。",[12,203,204],{"id":204},"和竞品对比",[136,206,207,223],{},[139,208,209],{},[142,210,211,214,217,220],{},[145,212,213],{},"维度",[145,215,216],{},"未来医生",[145,218,219],{},"健康160",[145,221,222],{},"平安健康",[155,224,225,239,253,267,281],{},[142,226,227,230,233,236],{},[160,228,229],{},"定位",[160,231,232],{},"临床决策辅助与医疗 AGI 架构",[160,234,235],{},"挂号加互联网医院",[160,237,238],{},"保险协同加企业福利",[142,240,241,244,247,250],{},[160,242,243],{},"起步价",[160,245,246],{},"官网未公开,需联系销售",[160,248,249],{},"挂号 0 元服务费",[160,251,252],{},"会员制,权益含问诊",[142,254,255,258,261,264],{},[160,256,257],{},"面向对象",[160,259,260],{},"医院与机构为主",[160,262,263],{},"个人患者为主",[160,265,266],{},"个人与企业",[142,268,269,272,275,278],{},[160,270,271],{},"强项",[160,273,274],{},"判断流程拆解、证据双向",[160,276,277],{},"号源直连医院",[160,279,280],{},"履约网络、保单联动",[142,282,283,286,289,292],{},[160,284,285],{},"短板",[160,287,288],{},"无公开验证数据",[160,290,291],{},"跨省覆盖弱",[160,293,294],{},"价格不透明",[16,296,297,300],{},[19,298,299],{},"怎么选",":要在院内试临床决策辅助、愿意陪着打磨流程,未来医生是少数把推理步骤摊开的产品;要今天就挂上号、看上医生,健康160 更实际;要给员工配一套能落地的健康服务,平安健康的履约网络更成熟。",[12,302,304],{"id":303},"faq","FAQ",[55,306,308],{"id":307},"q-未来医生现在能直接看病吗","Q: 未来医生现在能直接看病吗?",[16,310,311],{},"A: 线上能形成咨询意见,但页面写明需要真实接诊与临床确认,履约记录不作为已完成的诊疗。也就是说,它给的是策略与建议,开药、检查、住院仍要回到实体机构。急着看病,别从这条路走。",[55,313,315],{"id":314},"q-首页的病例是真的吗","Q: 首页的病例是真的吗?",[16,317,318],{},"A: 不是。页面自己标注\"架构机制演绎,非真实病例\"和\"产品状态演绎,非真实病例或履约记录\"。演示用来说明流程怎么跑,不能当作疗效证据。判断产品力,还得看它愿不愿意公开验证方案。",[55,320,322],{"id":321},"q-医院接入要准备什么","Q: 医院接入要准备什么?",[16,324,325],{},"A: 官网没写。按通行做法至少要准备三样:现有系统的接口文档、数据出域与脱敏的合规意见、参与科室的负责人。谈的时候把并发医生数、科室范围、数据留存位置定下来。",[12,327,328],{"id":328},"评测方法说明",[16,330,331],{},"元析评测按功能完整度、易用性、数据质量、性价比、客户支持五个维度打分,每项满分 10 分,取均值后按产品定位微调总分。未来医生的产品主张、流程拆分与演示标注于 2026-11 对照官网首页、MedGPT 页与患者服务页核对,未登录 Medex,未联系销售,报价以商务沟通为准。",[16,333,334,337],{},[19,335,336],{},"最后更新",":2026-11-16",{"title":339,"searchDepth":340,"depth":340,"links":341},"",2,[342,343,344,351,358,359,360,365],{"id":14,"depth":340,"text":14},{"id":28,"depth":340,"text":28},{"id":53,"depth":340,"text":53,"children":345},[346,348,349,350],{"id":57,"depth":347,"text":58},3,{"id":67,"depth":347,"text":68},{"id":77,"depth":347,"text":78},{"id":87,"depth":347,"text":87},{"id":96,"depth":340,"text":96,"children":352},[353,354,355,356,357],{"id":99,"depth":347,"text":100},{"id":106,"depth":347,"text":107},{"id":113,"depth":347,"text":114},{"id":120,"depth":347,"text":121},{"id":127,"depth":347,"text":128},{"id":134,"depth":340,"text":134},{"id":204,"depth":340,"text":204},{"id":303,"depth":340,"text":304,"children":361},[362,363,364],{"id":307,"depth":347,"text":308},{"id":314,"depth":347,"text":315},{"id":321,"depth":347,"text":322},{"id":328,"depth":340,"text":328},"healthcare",[368,369,370,371,372],"官网只有产品主张与架构图,没有公开的临床验证数据、样本量或对照结果","任何价格、开通方式、服务区域都要联系销售,采购方拿不到可对比的报价单","患者端多处写着咨询意见需真实接诊医生确认,意味着线上流程尚未独立完成诊疗","Medex 标注 v.01,功能边界与稳定性还在早期,机构接入要留调试期","中文站信息密度高,术语自造成分大,新读者要花时间分清 MedGPT、Medex、EvidenceOS 各管什么",null,"2026-11-16","未来医生评测:官网不公开任何报价,需联系销售;首页把 MedGPT 拆成状态与目标、候选与证据、批判与修复、决策性验证、策略审阅包五步,并标注演示内容非真实病例。适合关注临床决策辅助的机构,不适合想立刻问诊的个人。",false,"md",{},true,"今天就想找医生看报告、开药或复诊的个人用户","\u002Ftools\u002Fhealthcare\u002Fmedlinker",{"free":376,"startingPrice":339,"currency":383,"billingPeriod":384,"notes":385},"CNY","按量","官网未公开报价,需联系销售。首页只给患者服务、MedGPT、Medex 体验与机构合作入口,没有套餐、药价、问诊单价或会员价,也未列出服务开通条件。价格于 2026-11 核对官网。",[387,388,389,390,391],"MedGPT 把一次临床判断拆成状态与目标、候选与证据、批判与修复、决策性验证、策略审阅包五步,流程可追问","EvidenceOS 同时收支持证据、反方证据与适用边界,不只看有利文献","Medex 让医生的修订进入推理本身,改动后系统重算受影响的判断,版本号标到 v.01","患者端设路径经理角色,全病程档案保留上下文与决策历史,减少重复描述","站内明确标注\"架构机制演绎,非真实病例\",没有把演示包装成疗效","cn",7.4,{"features":395,"ease":393,"data":393,"price":396,"support":393},7.8,7.1,{"title":5,"description":375},"tools\u002Fhealthcare\u002Fmedlinker",[400,401,402,216],"医疗健康","临床决策辅助","互联网医院","https:\u002F\u002Fwww.medlinker.com","北京智医方程科技有限公司","Rju325ikHJY-D0casM3mft1nEX5ggvCdPPOhWJ6h5A0",1016,[408,418,426],{"path":409,"toolName":410,"description":411,"score":412,"pricing":413,"vendor":416,"date":417,"category":366},"\u002Ftools\u002Fhealthcare\u002Fdxy","丁香医生","丁香医生是丁香园旗下院外健康平台,集团官网写明注册医师 450 万+,App 首次问诊 9.9 元起,科普内容有医生审稿。它适合药企做患者教育、个人问小病,不适合当医院信息系统用,也不做医保结算,问诊只是轻咨询。",8.6,{"free":379,"startingPrice":339,"currency":383,"billingPeriod":414,"notes":415},"年","C 端免费使用,问诊按次付费,App Store 官方文案写明首次问诊 9.9 元起,复诊单价由接诊医生设定。药企内容合作、医院科普项目等机构业务官网未公开标准报价,需联系销售。价格核对时间 2026-11。","丁香园","2026-11-04",{"path":419,"toolName":420,"description":421,"score":422,"pricing":423,"vendor":420,"date":425,"category":366},"\u002Ftools\u002Fhealthcare\u002Falihealth","阿里健康","阿里健康是阿里系医药与医疗平台,官网披露天猫健康 4.83 万商家、大药房 123 万 SKU、码上放心服务 7100 家流通企业。强项在商家规模与药品追溯合规,适合药企做渠道,不适合想买独立 HIS 的医院,云医院由合作方实施。",8.5,{"free":376,"startingPrice":339,"currency":383,"billingPeriod":414,"notes":424},"C 端购药与问诊按件、按次付费,无独立订阅套餐。天猫健康入驻涉及保证金与技术年费,码上放心按追溯码用量或年度服务计费,官网均未公开标准报价,需联系销售。价格核对时间 2026-11。","2026-10-22",{"path":427,"toolName":428,"description":429,"score":430,"pricing":431,"vendor":428,"date":433,"category":366},"\u002Ftools\u002Fhealthcare\u002Fhaodf","好大夫在线","好大夫在线收录 10450 家医院、931617 位大夫,App 写明 28 万医生入驻、服务 8900 万患者。它是医生个人品牌的入口,问诊价格由医生定,适合副主任以上医生和找专病专家的患者。不适合急诊,入驻免费但抽成不公开,签约前要多看同城案例。",8.3,{"free":379,"startingPrice":339,"currency":383,"billingPeriod":414,"notes":432},"患者浏览医生主页、看评价免费,图文、电话、视频问诊按医生自报价付费,私人医生与优选会员为付费服务。医生入驻不收费。平台抽成比例与机构合作报价官网未公开标准报价,需联系销售。价格核对时间 2026-11。","2026-10-29",1794788232615]